Please Wait
Applying Filters...
Menu
Xls

Digital Content read-more

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

https://www.prnewswire.com/news-releases/boehringers-zongertinib-receives-priority-review-from-us-fda-for-the-treatment-of-her2-erbb2-mutant-advanced-non-small-cell-lung-cancer-302379614.html

PR NEWSWIRE
19 Feb 2025